Early Diagnosis and Disease Monitoring: Pathology and Biomarkers


Course Information

Therapautic Area: Neurology
Format(s): Webcast
Credit(s): .50 AMA PRA Category 1 Credit(s)™
Activity Dates: December 7, 2017 to December 6, 2018


Program Overview

In this module of a Four-Part Expert Interview Series, Dr. James E. Galvin, along with Dr. Richard S. Isaacson, course chair, will relay optimal strategies for early diagnosis of Alzheimer’s disease (AD). Signs and symptoms for the mild, moderate and severe forms of AD will be analyzed, as well as modifiable and non-modifiable risk factors. The faculty will also review biomarkers of disease, along with their clinical relevance. Upon completing this educational activity, participants will feel more confident in their understanding of early diagnosis and disease monitoring in the AD patient population.

Target Audience

Neurologists, internists, nurse practitioners, nurses and other healthcare professionals involved in the management of patients with Alzheimer’s disease.

Learning Objectives

I. Review the pathology of Alzheimer’s disease, including disease monitoring and specific biomarkers for early diagnosis

II. Identify the assessment and testing strategies for early diagnosis, monitoring, and personalized treatment of AD


Isaacson Head ShotRichard S. Isaacson, MD
Associate Professor of Neurology
Director, Alzheimer’s Prevention Clinic
Weill Cornell Medicine
New York Presbyterian Hospital
New York, New York



Screen Shot 2017-12-06 at 10.59.46 AMJames E. Galvin, MD, MPH
Professor and Associate Dean for Clinical Research
Director, Comprehensive Center for Brain Health
Charles E. Schmidt College of Medicine
Florida Atlantic University
Boca Raton, Florida


Disclosures of Conflict of Interest

It is the policy of AcademicCME that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity.

Faculty Relationship Identified With:
James E. Galvin, MD, MPH Nothing to disclose.

Planners, Managers, Reviewers

Timothy Hayes, MD, PhD; Emma Boring; Nicole Brestowski, Chelsey Benedek and Kim Cheramie, MSN, RN-BC hereby state that neither they nor their spouse/life partner have any financial relationships to products or devices with any commercials interest related to the content of this activity of any amount during the past 12 months.

Accreditation Statement

AcademicCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AcademicCME is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation

Credit Designation Statement

AcademicCME designates this enduring material for a maximum of .50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AcademicCME designates this enduring material for a maximum of .50 CNE contact hour(s).

Financial Support

This activity has been supported by an independent educational grant from Biogen.

Provided by AcademicCME-web